Iridian Asset Management’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-3,215,862
| Closed | -$98.4M | – | 82 |
|
|
2016
Q2 | $98.4M | Sell |
3,215,862
-1,292,487
| -29% | -$39.5M | 0.91% | 42 |
|
|
2016
Q1 | $169M | Buy |
4,508,349
+617,277
| +16% | +$23.1M | 1.43% | 29 |
|
|
2015
Q4 | $168M | Sell |
3,891,072
-1,389,236
| -26% | -$60M | 1.38% | 31 |
|
|
2015
Q3 | $198M | Sell |
5,280,308
-522,777
| -9% | -$19.6M | 1.67% | 26 |
|
|
2015
Q2 | $197M | Buy |
5,803,085
+391,520
| +7% | +$13.3M | 1.55% | 32 |
|
|
2015
Q1 | $192M | Buy |
5,411,565
+1,432,661
| +36% | +$50.7M | 1.61% | 30 |
|
|
2014
Q4 | $136M | Buy |
3,978,904
+593,990
| +18% | +$20.2M | 1.26% | 33 |
|
|
2014
Q3 | $131M | Buy |
3,384,914
+688,698
| +26% | +$26.6M | 1.35% | 33 |
|
|
2014
Q2 | $105M | Buy |
2,696,216
+128,290
| +5% | +$4.99M | 1.08% | 36 |
|
|
2014
Q1 | $87.8M | Buy |
+2,567,926
| New | +$87.8M | 1% | 37 |
|